Evaluating the Efficacy and Safety of product Petsaffa Tablets in patients suffering from Constipation, gas and acidity
- Conditions
- Health Condition 1: K928- Other specified diseases of the digestive system
- Registration Number
- CTRI/2023/03/051058
- Lead Sponsor
- Divisa Herbals Pvt. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Age Between 18 and 80
2.Subjects suffering from Constipation, Gas and Acidity
3.Subjects willing to sign ICF
4.Subjects willing to refrain taking any other similar medication during the study period.
1.Pregnant, breast-feeding subjects undergone any surgery and else take taken part in any clinical trial.
2.Participation in any other clinical study (device or drug) within 30 days prior to Screening.
3.Subjects with clinically significant serious cardiovascular, cerebrovascular, respiratory, hepatic, renal disease, congenital or any other disorder
4.Subject with abnormal lab values detected at the time of screening shall be excluded.
5.A known history or present condition of allergic response to pharmaceutical products its components or ingredients in the investigational product.
6.Pre-existing systemic disease necessitating long-term medications.
7.Genetic and endocrinal disorder.
8.Not willing to sign the ICF or give the consent.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method